Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial 0 20.06.2024 19:22 CNBC Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
